Đang chuẩn bị liên kết để tải về tài liệu:
BRCA2 carriers with male breast cancer show elevated tumour methylation

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Male breast cancer (MBC) represents a poorly characterised group of tumours, the management of which is largely based on practices established for female breast cancer. However, recent studies demonstrate biological and molecular differences likely to impact on tumour behaviour and therefore patient outcome. | BRCA2 carriers with male breast cancer show elevated tumour methylation

TÀI LIỆU LIÊN QUAN

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil

Is RNASEL:P.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotypespecific approaches to ovarian cancer prevention

MiRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2- germline mutation carriers in Brazil

Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)

Understanding of BRCA VUS genetic results by breast cancer specialists

A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers

Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer

BRCA2 carriers with male breast cancer show elevated tumour methylation
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.